Novel strategy to transform a commercially available iboga alkaloid to post-iboga alkaloids
KAIST chemists have synthesized seven different iboga and post-iboga natural products from commercially available catharanthine by mirroring nature's biosynthetic post-modification of the iboga skeleton.